Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...

全面介紹

書目詳細資料
Main Authors: Ziad Hijazi, Paolo Verdecchia, Jonas Oldgren, Ulrika Andersson, Gianpaolo Reboldi, Giuseppe Di Pasquale, Giovanni Mazzotta, Fabio Angeli, John W. Eikelboom, Michael D. Ezekowitz, Stuart J. Connolly, Salim Yusuf, Lars Wallentin
格式: Article
語言:English
出版: Wiley 2019-01-01
叢編:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
主題:
atrial fibrillation
biomarker
left ventricular hypertrophy
risk prediction
在線閱讀:https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

因特網

https://www.ahajournals.org/doi/10.1161/JAHA.118.010107

相似書籍